Chaobin B. He
State Key Laboratory Of Oncology In South China, PR
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 53 publications
Efficacy of immune checkpoint inhibitors combined with different chemotherapy in recurrent pancreatic cancer: a retrospective study.
Journal: Frontiers in immunology
Published: March 30, 2026
Anti-PD-1 blockade reverses low-intensity electric stimulation-driven pancreatic cancer progression.
Anti-PD-1 blockade reverses low-intensity electric stimulation-driven pancreatic cancer progression.
Journal: Frontiers in immunology
Published: January 21, 2026
Efficacy of irreversible electroporation combined with immunotherapy versus irreversible electroporation alone in locally advanced pancreatic cancer: a propensity score-matched retrospective study.
Journal: Frontiers in immunology
Published: April 30, 2025
Enhancing pancreatic cancer treatment: the role of H101 oncolytic virus in irreversible electroporation.
Journal: Frontiers in immunology
Published: January 17, 2025
The Prognostic Significance of the CALLY Index in Ampullary Carcinoma: An Inflammation-Nutrition Retrospective Analysis.
Journal: Journal of inflammation research
Published: September 11, 2024
Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer [Cancer Lett. 502 (2021) 9-24].
Journal: Cancer letters
Published: February 13, 2024
Modified staging system of positive lymph nodes based nomogram in intrahepatic cholangiocarcinoma.
Journal: Cancer cell international
Published: February 02, 2023
Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: October 08, 2022
An Inflammatory Response-Related Gene Signature Reveals Distinct Survival Outcome and Tumor Microenvironment Characterization in Pancreatic Cancer.
Journal: Frontiers in molecular biosciences
Published: February 15, 2022
Progression Patterns and Post-Progression Survival in Recurred Intrahepatic Cholangiocarcinoma Patients: A Novel Prognostic Nomogram Based on Multicenter Cohorts.
Journal: Frontiers in oncology
Published: December 09, 2021
Irreversible Electroporation Plus Anti-PD-1 Antibody versus Irreversible Electroporation Alone for Patients with Locally Advanced Pancreatic Cancer.
Journal: Journal of inflammation research
Published: August 03, 2021
Comparative Recurrence Analysis of Pancreatic Adenocarcinoma after Resection.
Journal: Journal of oncology
Published: July 21, 2021
Last Updated: 09/26/2026